Accueil>>Signaling Pathways>> GPCR/G protein>> Ras>>Z62954982

Z62954982 (Synonyms: ZINC08010136)

Catalog No.GC39763

Le Z62954982 (ZINC08010136) est un inhibiteur de Rac1 (IC50=12μM) puissant, sélectif et perméable aux cellules qui est 4fois plus efficace que le NSC23766 (IC50=50μM).

Products are for research use only. Not for human use. We do not sell to patients.

Z62954982 Chemical Structure

Cas No.: 1090893-12-1

Taille Prix Stock Qté
1mg (99.87 mM * 24.1 μL in DMSO)
68,00 $US
En stock
5mg (99.87 mM * 120.5 μL in DMSO)
189,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Z62954982 (ZINC08010136) is a potent, selective and cell-permeable Rac1 (IC50=12 μM) inhibitor that is 4 times more effective than NSC23766 (IC50=50 μM). Z62954982 disrupts the Rac1/Tiam1 complex and decreases cytoplasmic levels of active Rac1 (GTP-bound Rac1), without affecting the activity of other Rho GTPases (such as Cdc42 or RhoA)[1][2].

[1]. Nicola Ferri,et al. Virtual Screening Approach for the Identification of New Rac1 Inhibitors. J Med Chem. 2009 Jul 23;52(14):4087-90. [2]. Xun E Zhang, et al. Activation of RhoA, but Not Rac1, Mediates Early Stages of S1P-Induced Endothelial Barrier Enhancement. PLoS One. 2016 May 17;11(5):e0155490. [3]. Min Yu, et al. Lack of BCR and Abr Promotes Hypoxia-Induced Pulmonary Hypertension in Mice. PLoS One

Avis

Review for Z62954982

Average Rating: 5 ★★★★★ (Based on Reviews and 37 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Z62954982

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.